Opiranserin
Product Specifications
CAS Number
1441000-45-8
Target
GlyT|||P2X Receptor|||5-HT Receptor
Related Pathways
Membrane transporter/Ion channel|||GPCR/G Protein|||Neuroscience
Bioactivity
Opiranserin is a development as an injectable agent for the treatment of postoperative pain. Opiranserin is a non-opioid and non-NSAID analgesic candidate and is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A) (IC50s: 0.86 and 1.3 ?M, respectively) . Opiranserin displays antagonistic activity on rP2X3 (IC50=0.87 ?M) .
Smiles
C(NC(=O)C1=CC(OC)=C(OCCCC)C(OC)=C1)C2(N(C)C)CCOCC2
Molecular Formula
C21H34N2O5
Molecular Weight
394.51
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
N2050-06R-PE 200 µL
Nerve Growth Factor, beta (NGF, Beta Nerve Growth Factor, Beta Nerve Growth Factor Precursor, Beta NGF, HSAN5, Nerve Growth Factor beta, Nerve Growth Factor beta Polypeptide, Nerve Growth Factor beta Subunit, NGFB) (PE) discontinued
Ask
View Details